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West Nile virus (WNV) is a member of the Japanese encephalitis
serogroup of ﬂaviviruses which includes other medically important,
neuro-invasive viruses, such as Japanese encephalitis virus (JEV),
Murray Valley encephalitis (MVE), and St Louis encephalitis virus
(SLEV) (Calisher et al., 1989). The virus is endemic throughout Africa,
the Middle East, parts of Asia, and Europe, however since a 1999
outbreak in the USA, WNV has emerged as the most common cause of
arboviral encephalitis in North and Middle America (Petersen, 2009).
An unusually high percentage of neurological infections associated
with WNV circulated in the Americas compared to the relatively low
neuro-invasiveness of WNV strains previously circulated in the Old
World initiated studies on identifying viral determinants of the high
neuro-invasiveness of the American strain. Based on serological and
genetic data, WNV strains have been grouped into two distinct
lineages, lineage 1 and lineage 2 (Lanciotti et al., 2002). The highly
neuro-invasive New York 99 strain (NY99) belongs to lineage 1 which
also contains a relatively benign Australian strain Kunjin (KUN)
(Lanciotti et al., 2002). KUN virus was ﬁrst isolated in 1960 in NorthQueensland (Doherty et al., 1963) and since then has been found to be
endemic in Australia (Hall et al., 2002). KUN causes mainly
asymptomatic infection and was associated with only a handful
number of cases of mild encephalitis and no death (Hall et al., 2002).
Immunization of mice with KUN virus or plasmid DNAs encoding a
full-length cDNA copy of the KUN genome provides highly effective
protection against NY99 (Hall et al., 2003) and therefore KUN has
been considered as potential vaccine candidate against NY99.
Although both NY99 and KUN are lethal after peripheral injection in
weanling (less than 21 days old) mice, the 50% lethal dose (LD50) for
NY99 is substantially lower than for KUN. In contrast, only NY99 and
not KUN is lethal after peripheral injection in adult (more than 21
days old) mice, thus providing a convenient model for identifying
virulence determinants.
Studies comparing the neuro-invasiveness of NY99 with other
WNV strains as well as with genetically engineered viral mutants in
mice identiﬁed a number of virulence determinants residing in both
structural and non-structural genes as well as in the 3′ untranslated
region (UTR) (Beasley et al., 2004; Beasley et al., 2001, 2002; Beasley
et al., 2005; Davis et al., 2007; Wicker et al., 2006; Zhang et al., 2006).
Analysis of chimeric WNV viruses between NY99 strain and lineage 2
attenuated W956 strain showed that high cytopathicity and high
virulence of NY99 strain was associatedwith determinants in the non-
structural coding region (Borisevich et al., 2006). Previous studies
with KUN demonstrated a role for NS2A in virus-induced cytopathi-
city in cells and virulence in mice and showed that a single point
mutation from alanine to proline at position 30 (A30P) in NS2A
signiﬁcantly reduced virus-induced cytopathicity in cells and
Fig. 1. Construction of aWNVNY99 clone and recovery of infectious NY99 virus. (A) Schematic representation of the cloning strategy. NY99 viral RNAwas reverse transcribed and the
cDNA fragments were ligated to form pWN NY99 1 (fragments 1–2880 and 5781–11029 nt) and pWN NY99 2 (fragments 2881–5780). To create infectious virus pWN NY99 1 and 2
were digested with BspEI and BsiWI, in vitro ligated, digested with SalI and in vitro transcribed to form full-length viral RNA. The RNAwas then electroporated into BHK-21 cells, and
virus was recovered. (B) Comparison of plaque morphology of BHK, vero, and A549 cells infected at an MOI of ~1 with wt NY99 and virus recovered from in vitro ligated pWN NY99.
The cells were then overlaid with 0.75% LMT agarose in DMEM containing 2% FCS. At the indicated time, the cells were ﬁxed with 4% formaldehyde and stained with 0.2% crystal
violet. (C) Growth kinetics of wt NY99 and cloned NY99 in A549 cells infected at anMOI of ~1. At the indicated time post-infection culture supernatants were collected and viral titres
were determined by plaque assay on Vero cells. (E) Survival of adult (4–5 weeks old) Swiss outbred mice infected with NY99-4132 isolate and virus recovered from NY99-4132
infectious clone. Groups of 10 mice were i.p. injected with 10, 100 or 1000 pfu of each virus. The mice were monitored for 14 days post-infection for signs of encephalitis at which
point the mice were sacriﬁced. All mouse experiments in this were conducted with approval from the University of Queensland Animal Experimentation Ethics Committee in
accordance with the guidelines for animal experimentation as set out by the National Health and Medical Research Council, Australia.
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65M. Audsley et al. / Virology 414 (2011) 63–73virulence in mice (Liu et al., 2004; Liu et al., 2006). Similar studies
with NY99 virus also showed a key role for NS2A in virus-induced
cytopathicity and virulence, however A30P mutation was not shown
to have such a dramatic effect on NY99 viral properties as it had in
KUN studies (Rossi et al., 2007) suggesting a potential contribution of
other residues in NS2A different between NY99 and KUN viruses to
the WNV-induced cytopathicity and virulence. Here we report the
generation and characterization of infectious clone of NY99 isolate
4132 and of a number of chimeric viruses containing various parts of
NY99 4132 genomes on KUN background and show that the majority
of viral determinants responsible for high virulence of NY99 and low
virulence of KUN reside in the 5′UTR and nonstructural coding region.
In addition, by analyzing the properties of chimeric NY99 viruses
containing wild type and A30P-mutated KUN NS2A we provide
further evidence for the role of NS2A protein in WNV-induced
cytopathicity and virulence.
Results
Generation of two plasmid system for infectious RNA for NY99 bird
isolate 4132 and characterization of recovered virus
In order to initiate studies on identifying virulence determinants
between NY99 and KUN strains, a two plasmid system for the
generation of an infectious RNA for NY99 4132 isolate was constructed.
Viral RNAwas reverse transcribed and fragmentsWN1/2,WN3/4,WN5/
6,WN7/10 andWN8/9 spanning the entire genomewere PCR ampliﬁed
(Fig. 1A). PCR fragments were then cloned individually and assembled
into two plasmids, pWNV1 covering nucleotides 1–3324 and 5713–
11029 in pBR322 vector and pWN2 covering nucleotides 2710–5139 of
NY99 4312 genome in pBluescript II KS+vector.
Sequence differences between KUN and NY99 genomes
cDNA derived from RNA isolated from virus recovered from the
NY99 4132 infectious clone and cDNA generated from viral RNA
isolated from the initial stock of NY99 4312 virus were sequenced and
shown to be identical (not shown). Sequence comparison between
published NY99 prototype 382–99 isolate (Lanciotti et al., 2002) and
the sequence of NY99 4132 virus recovered from infectious RNA
generated from two plasmid system revealed 7 nucleotide differences
with four of them leading to the amino acid changes including two
non-conservative changes from C to R at position 168 of NS2A protein
and from Q to R at position 110 of NS3 protein (Table 1). Sequence
comparison between NY99 4312 and KUN strains revealed 88.6%
homology at the nucleotide level and 97.8% homology at the amino
acid level. A total of 77 amino acid substitutions with 34 of them being
non-conservative were different between these two strains (Table 2).
The structural genes accounted for 25 amino acid changes (13 non-Table 1
Differences between the sequences of published NY99 382–99 isolate (AF404756) and
NY99 4132 isolate (HQ596519).
Nucleotide
position
Gene aa position in
polyprotein
and encoded
protein
NY99
(AF404756)
NY99
(HQ596519)
Aa
code
Amino
acid
aa
code
Amino
acid
450 prM – ATC I ATT –
2321 E 742 (452) TTA L TCA S
4027 NS2A 1311(168) TGC C CGC R
4195 NS2A 1367(224) ACA T GCA A
4939 NS3 1615(110) CAG Q CGG R
7011 NS4B – TTT F TTC –
10624 3′UTR – C T
Nucleotides in bold in the corresponding codons indicate different nucleotides.
Sequence of NY99 4132 isolate have been deposited to GeneBank and obtained
accession numbers HQ596519.conservative) while the remaining 52 changes (21 non-conservative)
were located in the nonstructural region. Interestingly, amino acids at
positions 168 in NS2A (C) and position 110 in NS3 (Q) in KUN were
the same as in published NY99 382–99 sequence. In addition to
changes in the coding region, 3 nucleotides were different in the 5′
UTR (nts 50–52, AAC in NY99 4312 and TTG in KUN). There were also
52 nucleotide substitutions plus a 7-nucleotide insertion in the 3′UTR.
None of these substitutions in the 3′UTR however, were located in the
last 108 nucleotides containing highly conserved cyclization sequence
and stem–loop structure.
NY99 4132 isolate and virus derived from its infectious cDNA clone
replicate with similar efﬁciencies in cells and mice
We compared the plaque morphology of virus recovered from the
NY99 4132 cDNA clone with the parental isolate in Vero cells (Fig. 1B)
and the virus growth kinetics in Vero and A549 cells (Fig. 1C). Both the
plaque size and replication kinetics of the cloned NY99 4132 were
virtually identical to the parental NY99 4132 isolate. We then
compared the virulence of the wt NY99 4132 and the cloned NY99
4132 in 4- to 5-week-old Swiss outbred mice (Fig 1D) and observed
no difference in survival at 10, 100, or 1000 pfu (p=0.9, 0.6 and 0.3,
respectively). Thus the two plasmid system for recovery of infectious
RNA from the NY99 4132 isolate produces virus indistinguishable
from the original virus isolate and therefore is suitable for genetic
manipulations in further studies.
5′UTR contributes to the higher virulence of NY99 4132 isolate
KUN infectious clone FLSDX was chosen for generating the ﬁrst set
of chimeric viruses to see whether the substitution of various regions
in KUN genome with those derived from NY99 genome will provide
an advantage in replication and increase in virulence. Given
signiﬁcant number of substitutions in the UTRs, we ﬁrst generated
KUN chimeric viruses containing either NY99 5′UTR, 3′UTR or 5′UTR
and 3′UTRs together (Fig. 2A). Plaque assay of recovered viruses in
BHK, Vero and A549 cells showed that neither 5′UTR or 3′UTR alone
nor 5′UTR and 3′UTR together provided a noticeable advantage in
viral spread, as the plaque sizes of chimeric viruses in all 3 cell lines
were similar to those of parental KUN virus (Fig. 2B). Multiple growth
curve analysis of KUN-NY99 UTR chimeric viruses in Vero and C6/36
cells also showed little differences in the replication kinetics and virus
titres between parental KUN and chimeric viruses containing NY99
UTRs (Fig. 2C). Surprisingly, when the chimeric viruses were
examined for virulence in weanling 19 day old Swiss outbred mice,
the KUN-NY99 5′UTR chimeric virus was signiﬁcantly more virulent
than wt KUN virus at 10 pfu dose (Fig. 2D; pb0.01). In contrast, the
virulence of KUN-NY99 3′UTR or KUN-NY99 5′UTR/3′UTR chimera
was not signiﬁcantly different from the wt KUN virus at the same dose
(Fig. 2D, p=0.8 and p=0.4, respectively). The results suggest a role
for the 3 nucleotide difference in the 5′UTR in the higher virulence of
WNV in mice.
Nonstructural coding region provides signiﬁcant contribution to the
virulence of NY99 4132 strain
To assess the contribution in virulence of the nonstructural geneswe
extended the regions for substitution ﬁrst to the NS5-3′UTR region and
then to theNS2A-3′UTR region (Fig. 3A). Both chimeras produced larger
plaques than parental KUN in BHK, Vero and A549 cells, with plaques in
BHK and Vero having sizes similar to those produced by the NY99 4312
virus (Fig. 3B). The plaques in A549 cells on average were smaller for
chimeric viruses compared with NY99 4312 virus, although some of
them, particularly for the KUN-99 5′/NS2A-3′UTR chimera, were very
similar to NY99 4132 plaques (Fig. 3B). Replication of KUN-99 NS5-3′
UTR chimera in Vero cells was slightly more efﬁcient than that of KUN
Table 2
Amino acid differences between KUN FLSDX and NY99 4132 infectious cDNA clones.
Gene aa position in
polyprotein
(corresponding
protein)
KUN-FLSDX NY99 4132 Number of
substitutions
in each gene
(number of
non-conservative
changes)
Amino acid Amino acid
C 28 T I 4 (2)
41 R K
44 T I
71 S G
prM 113(8) F V 7 (3)
120(15) G S
145(40) I V
166(61) H Y
195(90) L S
228(123) S A
279(174) A V
E 356(66) E D 14 (8)
379(89) S A
382(92) K R
416(126) T I
446(156) F S
449(159) T V
452(162) A T
489(199) S N
519(229) E G
521(231) N T
600(310) R K
628(338) I V
655(365) S A
E 700(410) A T
NS1 879(88) I V 9 (0)
893(102) R K
926(135) I V
961(170) R K
997(206) F L
1027(236) V I
1036(245) I V
1055(264) S N
1118(327) N S
NS2A 1255(112) A V 6 (2)
1262(119) Y H
1272(129) M I
1311(168) C R
1355(212) F L
1366(223) V I
NS2B 1438(64) G S 2 (1)
1477(103) A V
NS3 1520(15) R K 11 (6)
1615(110) Q R
1680(174) V I
1754(249) A P
1809(303) R K
1836(331) A S
1861(356) I T
1889(383) I V
1912(406) V I
1991(486) C F
2115(610) S A
NS4A 2129(5) F L 5 (1)
2209(85) V A
2213(89) A V
2265(141) L M
2269(145) G S
NS4B 2288(15) G S 7 (3)
2296(23) T V
2302(29) I M
2387(114) S A
2449(176) V I
2459(186) L V
2518(245) V I
NS5 2553(25) I T 12 (8)
2561(33) T I
2575(47) R G
2577(48) I V
2690(162) L I
Table 2 (continued)
Gene aa position in
polyprotein
(corresponding
protein)
KUN-FLSDX NY99 4132 Number of
substitutions
in each gene
(number of
non-conservative
changes)
Amino acid Amino acid
NS5 2705(177) K R
2775(247) K R
2840(567) E D
3059(531) R K
3181(653) S F
3259(731) T V
3405(877) S A
Total 77 (33)
66 M. Audsley et al. / Virology 414 (2011) 63–73but less efﬁcient than that of NY99 4132 virus, while replication
efﬁciency of KUN-99 5′/NS2A-3′UTR chimera was indistinguishable
from NY99 4132 virus early in infection (24 h p.i.) with some decline in
efﬁciency compared to NY99 4132 virus observed at later time points
(48 and 72 h p.i.) (Fig. 3C). Both chimeras replicated with efﬁciency
similar to KUN and lower than NY99 in C6/36 cells while their
replication efﬁciency in A549 cells was intermediate between KUN
and NY99 (Fig. 3C). Although replication efﬁciency of KUN-99 NS5-3′
UTR and KUN-99 5′/NS2A-3′UTR chimeras appeared to vary in different
cells, the common trend was that these chimeras replicated with
efﬁciencies which were intermediate between parental KUN and NY99
viruses.
We then examined virulence of these chimeric viruses after
intraperitoneal injection with 10 pfu virus in weanling (19 day old)
Swiss outbred mice. KUN-99 5′/NS2A-3′UTR and KUN-99 NS5-3′UTR
were clearly more virulent than parental KUN (pb0.001 and pb0.05,
respectively) (Fig. 3D). The average survival time for both chimeras
was shorter than for KUN, and LD50 for KUN-99 5′/NS2A-3′UTR
chimera was approaching that of NY99 (0.6 pfu and 0.4 pfu,
respectively, Table 3).
We then examined virulence of chimeras in adult (4 weeks old)
Swiss outbred mice. Our previous experiments showed that intraper-
itoneal infection with 1000 pfu of NY99 4132 virus resulted in 80–90%
mortality, while the same dose of KUN virus did not kill anymice (Hall
et al., 2003). Thus 1000 pfu was used in this experiment. KUN-99 5′/
NS2A-3′UTR chimera killed 40% ofmice by day 11, while KUN-99 NS5-
3′UTR killed 20% of mice by day 11 with 10% more mice dying at day
14, which was signiﬁcantly less than NY99 (pb0.01 and pb0.05,
respectively) (Fig. 3D). As expected, none of the mice died after KUN
infection, and 90% mice died by day 12 after NY99 infection (Fig. 3D).
The results in adult mice correlated with the results in weanling mice
in terms of increased virulence of the chimeras compared to KUN,
however, even KUN-99 5′/NS2A-3′UTR chimera was still signiﬁcantly
less virulent than NY99 virus in adult mice.
KUN NS2A in combination with A30P substitution signiﬁcantly decrease
cytopathicity and virulence of NY99 virus
Our previous studies with NS2A A30P mutant of KUN virus
identiﬁed NS2A as one of the major determinants of viral cytopathi-
city in cells and virulence inmice (Liu et al., 2004; Liu et al., 2006). The
increased virulence of NS2A-3′UTR chimera over NS5-3′UTR chimera
(Fig. 3) also indicated a potential role for NY99 NS2A together with
other NS proteins in virus virulence. Other studies with WNV also
showed an important role for NS2A in virus-induced cytopathicity and
virulence (Rossi et al., 2007). Therefore it was logical to assume that
NS2A is likely to provide a certain contribution to the difference in
virulence between KUN and NY99 4312 viruses. To test this
hypothesis, we generated chimeric virus NY99-KUN NS2A containing
KUN NS2A on the background of NY99 4132 genome (Fig. 4A).
However, plaque assays in BHK, Vero and A549 cells showed that this
Fig. 2. Characterization of chimeric KUN-NY99 viruses containing NY99 UTRs in KUN genome. (A) Schematic representation of the chimeric construct showing KUN sequence in grey
and NY99 sequence in white. The 5′ and 3′UTRs of NY99 (open boxes) were inserted into the KUN FLSDX clone instead of KUN UTRs (solid lines) to produce KUN-NY99 5′UTR, KUN-
NY99 3′UTR, and KUN-NY99 5′UTR/3′UTR chimeric constructs. (B) Comparison of plaque morphology in BHK-21 (3d.p.i), Vero (4d.p.i.) and A549 cells (5d.p.i.) infected with the
KUN-NY99 chimeric viruses. Cells in 6-well plates were infected at anMOI of 1 and overlaid with 0.75% LMT agarose in DMEM containing 2% FCS. At the indicated time, the cells were
ﬁxed with 4% formaldehyde and stained with 0.2% crystal violet. (C) Growth kinetics of wt and KUN-99 UTR chimeric viruses in Vero and C6/36 cells infected at an MOI of ~1. Viral
titres were determined by plaque assay on vero cells. Error bars represent standard deviation of duplicate samples (D) Survival of weanling (18–19 days old) Swiss-outbred mice
inoculated i.p. with 10 pfu of wt or chimeric virus. The mice were monitored for 14 days post-infection for signs of encephalitis at which point the mice were sacriﬁced.
67M. Audsley et al. / Virology 414 (2011) 63–73chimera was indistinguishable from the parental NY99 4312 virus
(Fig. 4B), and replicated with similar efﬁciency and was as cytopathic
as parental NY99 4132 virus in A549 cells (Fig. 4C). However, a
statistically signiﬁcant attenuation of NY99-KUN NS2A virulence was
observed in 4-week old mice compared to that of NY99 4132 virus(pb0.001, for all doses, Fig. 4D, Table 4) suggesting that NS2A is
indeed contributing to the difference in virulence between KUN and
NY99 4132 viruses.
To further clarify a role inWNV virulence for the Ala at position 30
in NS2A, which has been previously shown to signiﬁcantly attenuate
68 M. Audsley et al. / Virology 414 (2011) 63–73
Table 3
Virulence of chimeric KUN-NY99 viruses in 18–19 day old Swiss outbred mice after i.p.
injection.
Virus Dose (pfua) Mortality (%) A.S.T.b (Days) LD50c
NY99 100 10/10 (100%) 5.5 0.4 pfu
10 10/10 (100%) 5.8
1 9/10 (90%) 6.5
0.1 0/10 (0%) 14
KUN 1000 5/5 (100%) 7.8 17.8 pfu
100 4/5 (80%) 8.8
10 2/5 (40%) 8.5
1 2/5 (40%) 9
KUN-NY99 NS5-3′UTR 1000 6/6 (100%) 5.7 2.7 pfu
100 10/10 (100%) 6.3
10 9/10 (90%) 7.2
1 2/10 (20%) 9
0.1 0/10 (0%) 14
KUN-NY99 5′/NS2A-3′UTR 1000 6/6 (100%) 5.5 0.6 pfu
100 10/10 (100%) 5.9
10 10/10 (100%) 6.5
1 6/10 (60%) 6.8
0.1 2/10 (20%) 7
a pfu—plaque forming unit.
b A.S.T.—Average survival time.
c LD50—Lethal dosage (50%).
69M. Audsley et al. / Virology 414 (2011) 63–73KUN virus (Liu et al., 2006), we generated two NY99 viruses, one with
Ala 30 to Pro substitution in NY99 NS2A (NY99-NS2A/A30P), and
another one in which Ala 30 to Pro substitution was introduced on the
background of KUN NS2A in the NY99-KUN NS2A chimeric virus
(NY99-KUN NS2A/A30P) (Fig. 4A). Both A30P-mutant viruses pro-
duced smaller plaques than parental NY99 4132 or chimeric NY99-
KUN NS2A viruses in Vero and A549 cells (Fig. 4B). NY99-KUN NS2A/
A30P virus also replicated relatively less efﬁciently and was
signiﬁcantly less cytopathic than NY99 4132 in A549 cells (Fig. 4C).
Although the replication efﬁciency of NY99-NS2A/A30P was similar to
that of parental NY99 virus, the mutant virus was less cytopathic in
A549 cells (Fig. 4C). NY99/NS2A/A30P and NY99-KUN/NS2A/A30P
were then examined for virulence in adult 4 week old Swiss outbred
mice after intraperitoneal infection. Both A30P-mutant viruses were
attenuated compared to the parental NY99 4132 virus (NY99/NS2A/
A30P: 10 pfu pb0.05, 100 pfu pb0.001, 1000 pfu pb0.01, NY99-KUN /
NS2A/A30P pb0.0001 for all doses) with NY99-KUN NS2A/A30P virus
showing N1000-fold increase in LD50 value (Fig. 4D, Table 4). The LD50
of NY99/NS2A/A30P mutant was ~20- to 40-fold higher that of wt
NY99 4132 virus (Table 4). Thus, A30P mutation alone in the NY99
NS2A lead to noticeable decrease in cytopathicity and virulence, while
combination of A30P with other substitutions present in the KUN
NS2A lead to a signiﬁcant decrease in the cytopathicity and virulence
of NY99 virus. As KUN NS2A differs from NY99 4132 NS2A by 6 amino
acids (Table 2) it is not clear at this stage which of these 6 amino acids
act in accord with A30P in making the NY99-KUN/NS2A/A30P virus
signiﬁcantly less cytopathic and less virulent.
Discussion
Despite belonging to the same lineage I of West Nile viruses, the
circulating in North America NY99 strain and circulating in Australia
KUN strain of WNV differ greatly in their virulence in mice and their
ability to cause severe encephalitis in birds, horses and humans.
Although a number of studies identiﬁed genetic determinants of
virulence in the various parts of genome in pathogenic WNV strainsFig. 3. Characterization of chimeric KUN-NY99 viruses containing NY99 non-structural prot
KUN sequences in grey and NY99 sequences in while. The NS5-3′UTR and the 5′UTR/NS2A-3′
UTR and KUN-NY99 5′UTR/NS2A-3′UTR chimeric constructs. (B) Comparison of plaque morp
NY99 chimeric viruses. (C) Growth kinetics of wt and KUN-99 chimeric viruses in Vero, C6/36
vero cells. Error bars represent standard deviation of duplicate samples (D) Survival of wean
inoculated with 1000 pfu of wt or chimeric virus. The mice were monitored for 14 days po(Beasley et al., 2002; Beasley et al., 2005; Davis et al., 2007; Wicker
et al., 2006; Zhang et al., 2006), the viral determinants of the less
pathogenic KUN strain compared to the NY99 strain have not been
identiﬁed. In order to identify these determinants we ﬁrst constructed
a two plasmid system for generation of an infectious RNA of the NY99
4132 isolate and showed that recovered virus has properties identical
to those of the original isolate (Fig. 2). Previouslywe also generated an
infectious clone of KUN strain (Khromykh et al., 1998; Khromykh and
Westaway, 1994) which was used as a backbone for creating KUN-
NY99 chimeras. We have found six nucleotide changes in the coding
region and one in the 3′UTR of NY99 4132, compared with the
published sequence of NY99 382-99, of which four result in amino
acid changes. In particular, the Cys to Arg substitution in NS2A and Gln
to Arg in NS3 may be of some interest due to non-conservative nature
of these substitutions. Despite these differences, virus recovered from
infectious RNA for NY99-4132 isolate showed similar virulence in
mice to previously published data for other NY99 isolates (Beasley
et al., 2001). The appearance of these substitutions as the result of two
passages in C6/36 and two passages in Vero cells prior to isolating
viral RNA used for generation of cDNA fragments can also not be
excluded. Further detailed comparison of NY99-4132 isolate with
other previously and currently circulating North American WNV
isolates in mosquito, bird, horse and mouse models may prove to be
useful to determine if any differences in virulence exists between
them.
To initiate studies on identifying virulence determinants between
NY99 and KUN strains, we ﬁrst swapped the UTR regions in KUN virus
with those of NY99 strain. Surprisingly, the three nucleotide
differences in the NY99 5′UTR resulted in a signiﬁcantly more
pathogenic virus compared with KUN, despite similar replication
kinetics and cell spread in mammalian andmosquito cell lines (Fig. 2).
M-fold predictions of the NY99 and KUN 5′UTR structures show little
difference in structure stability, suggesting the AAC nucleotides
present in NY99 may enhance the binding of viral and/or unknown
host proteins which promote viral pathogenicity. Alignment of the 5′
UTR of complete WNV genomes available on Flavitrack (http://www.
carnot.utmb.edu/ﬂavitrack/) show that KUN is the only sequence with
TTG at nucleotides 50–52. The vast majority of sequences contain AAC
at nucleotides 50–52, suggesting that the TTG sequence in KUN
contributes to its attenuation, although other viral factors must also
be involved since other attenuated WNV isolates (such as B959
(Yamshchikov et al., 2004)) do contain the AAC sequence at
nucleotides 50–52. Surprisingly, the introduction of both the NY99
5′UTR and 3′UTRs together into KUN did not lead to increased
virulence compared to KUN in weanling mice (Fig. 3). Comparison of
NY99 with an attenuated American strain (Bird 1153) found that
mutations within NS4B, NS5 and 3′UTR were responsible for smaller
plaque sizes, temperature sensitivity and virulence in mice (Davis
et al., 2007). The temperature-sensitive phenotype was the result of
the 4 nucleotide changes in the 3′UTR, of which, KUN encodes one of
these nucleotide changes (T10767 matching T10774 from Bird 1153).
However, no difference in virulence in mice was detected between
NY99 and the 3′UTR only mutant (Davis et al., 2007) which is also the
case for KUN-NY99/3′UTR chimeric virus. This suggests that any
increase in virulence attributed to AAC in the 5′UTR is eliminated by
the differences in the 3′UTR when both of them are replaced. One
potential explanation could be that long range interactions between
homologous and heterologous 5′UTRs and 3′UTRs may alter the
overall RNA structure leading to different exposure of AAC/TTG region
for interactions with viral and/or host proteins.eins in KUN genome. (A) Schematic representation of the chimeric constructs showing
UTR regions of NY99 were inserted into KUN FLSDX clone to produce KUN-NY99 NS5-3′
hology in BHK-21 (3d.p.i), vero (4d.p.i.) and A549 cells (5d.p.i.) infected with the KUN-
and A549 cells infected at anMOI of ~1. Viral titres were determined by plaque assay on
ling (18–19 days old) mice inoculated i.p. with 10 pfu and adult (4 weeks old) mice i.p.
st-infection for signs of encephalitis at which point the mice were sacriﬁced.
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Table 4
Virulence of chimeric NY99-KUN viruses in 4-week old Swiss outbred mice after i.p.
injection.
Virus Dose (pfua) Mortality A.S.T.b (days) LD50c
NY99 1000 10/10 (100%) 5.6 b1 pfu
100 10/10 (100%) 5.6
10 10/10 (100%) 6.2
1 7/10 (70%) 8.6
NY99/NS2A/A30P 100 000 5/5 (100%) 6.4 21.4 pfu
10 000 9/10 (90%) 7.3
1000 8/10 (80%) 8.0
100 7/10 (70%) 9.7
10 4/10 (40%) 11.2
NY99-KUN/NS2A 100 000 9/10 (90%) 7.9 b10 pfu
10 000 6/10 (60%) 7.3
1000 8/10 (80%) 8.5
100 7/10 (70%) 8.6
10 6/9 (66.7%) 10.2
NY99-KUN/NS2A/A30P 100 000 4/5 (80%) 7.6 1000 pfu
10 000 6/10 (60%) 10.1
1000 5/10 (50%) 11.5
100 4/10 (40%) 11.8
10 3/10 (30%) 12.1
a pfu—plaque forming unit.
b A.S.T.—Average survival time.
c LD50—Lethal dosage (50%).
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virulence of NY99, we created chimeras KUN-99 5′/NS2A-3′UTR and
KUN-99 NS5-3′UTR (Fig. 1B). Both chimeras showed intermediate
replication, cell spread and virulence compared with NY99 and KUN
(Fig. 4), suggesting that the non-structural proteins are involved in
the increased pathogenicity of NY99. Moreover, the NS5 protein
appears to play a key role the increased virulence of chimeras as the
differences in mouse survival between KUN-99 5′/NS2A-3′UTR and
KUN-99 NS5-3′UTR were not signiﬁcant at any dosage in weanling or
adult mice. Given that 8 of the 12 amino acid differences between
NY99 and KUN are non-conserved (Table 2), it is reasonable to assume
that NS5 provides a large contribution to the increased virulence of
NY99. This is in agreement with our recent ﬁndings showing higher
resistance of NY99 NS5 to anti-viral activity of IFN compared to that of
KUN virus (Laurent-Rolle et al., 2010). However, the presence of other
NY99 non-structural proteins (NS2A-NS4B) in KUN-99 5′/NS2A-3′
UTR chimera was also beneﬁcial to the increased virulence in
weanling mice as the LD50 of this chimera was nearly the same as
wt NY99 virus (0.6 and 0.4 pfu, respectively, Table 3), while the LD50
of KUN-99 NS5-3′UTR chimera was somewhat higher (2.7 pfu).
The individual contribution of NS2A to the WNV virulence was
evaluated by creating chimeras containing KUN NS2A and its A30P
mutant (shown previously for KUN virus to signiﬁcantly decrease
cytopathicity in cells and virulence inmice) on the background of NY99
4132virus. A dramatic decrease in cytopathicity and signiﬁcant (N1000-
fold) attenuation in mice of the NY99-KUN/NS2A/A30P chimera thus
conﬁrms our previous observations with KUN virus on the crucial role
for the NS2A in WNV-induced cell cytopathicity (Liu et al., 2004; Liu
et al., 2006). Surprisingly, chimeric NY99 virus containingwt KUNNS2A
was as cytopathic in cells and only mildly attenuated in mice indicating
that NS2A alone is likely to provide only minor contribution to
the higher virulence of NY99 strain. Interestingly, introducing A30PFig. 4. Characterization of NY99-KUN chimeras viruses containing wt and A30P-mutaed KU
showing NY99 sequence in white and KUN sequence in grey. The KUN wt and A30P-mutate
clone to produce NY99-KUN/NS2A and NY99-KUN NS2A/A30P chimeric constructs. In additio
(B) Comparison of plaque morphology in, Vero (6d.p.i.) and A549 cells (4d.p.i.) infected wit
mutant viruses in A549 cells infected at an MOI of ~1. Viral titres were determined by plaque
and stained with 0.2% crystal violet. Methanol was added to each well and the amount of crys
represents 0% CPE). The error bars indicate the standard deviation of the duplicate wells. Erro
old) Swiss outbredmice infected with wt NY99 and chimeric/mutant viruses. Groups of 10m
days post-infection for signs of encephalitis at which point the mice were sacriﬁced.mutation alone in the NY99 background lead only tomoderate decrease
in cytopathicity in cells and only ~20-fold attenuation in adult mice,
similar to the previously published results by others (Rossi et al., 2007).
However when this mutation was combined with 6 other amino acid
substitutions present in KUN NS2A, the viral attenuation was much
more pronounced. It would therefore be interesting to investigate
which of these 6 substitutions provide such a profound cumulative
effect with A30P mutation. This may provide further insight into the
structure and functions of this multifunctional protein and its role in
viral pathogenesis.
The results determine the differences in the genome sequence
between a naturally attenuated Australian WNV KUN and highly
pathogenic WNV NY99-4132 isolate and identify the virulence
determinants between these two viruses in the 5′UTR and the non-
structural proteins, in particularly NS5. In addition, the results further
conﬁrm a role for the NS2A protein inWNV-induced cytopathicity and
pathogenicity.
Materials and methods
Cells and viruses
BHK cells weremaintained in Dulbecco'smodiﬁcation of minimum
essential medium (DMEM; Invitrogen) supplemented with 5% FBS.
Vero cells were maintained in DMEM containing 10% FBS. A549 cells
were maintained in DMEM/F12 medium (Invitrogen) containing 10%
FBS. BHK, Vero and A549 cells were grown at 37 °C in a CO2 incubator.
C6/36 cells were maintained in RPMI (Invitrogen) containing 10% FBS
and grown at 28 °C.
NY99-4132 isolate of West Nile virus was originally isolated on 27
August 1999 from infected American crow in Queens, New York,
passaged once in CrowVIC6 and once in C6/36 cells followed by two
passages in Vero cells and one passage in C6/36 cells to generate virus
used for RNA isolation.
Construction of two plasmid system for generation of infectious WNV
NY99 RNA
WNV NY99 4232 virus from culture ﬂuid of infected cells was
concentrated using Centricon column (Millipore) and viral RNA was
isolated using Nucleospin RNA virus isolation kit (Macherey-Nagel,
Dueren, Germany). Primers for RT-PCR o f viral RNA were designed
based on published WNV NY99 sequence (GeneBank ID number
AF260967). The RNA was reverse transcribed with AMV reverse
transcriptase (Promega) using the primers WN2, WN4, WN6, WN8,
andWN10 (Table 1). The resultant cDNAwas ampliﬁed using PfuUltra
(Invitrogen) and the primer pairs WN1 and WN2 (WN1/2, 3124 bp;
Fig. 1A), WN3 and WN4 (WN3/4, 3209 bp), WN5 and WN6 (WN5/6,
2239 bp), WN7 and WN10 (WN7/10, 2900 bp), and WN8 and WN9
(WN8/9, 696 bp). The cDNA fragments were sequenced to determine
a consensus sequence, and then cloned into EcoRV-digested pBlue-
script II KS+vector (Clontech) (referred to as pWN1/2, pWN3/4,
pWN5/6, pWN7/10, pWN8/9). pWN1 was created by assembling
WN1/2, WN5/6, WN7/10 and WN8/9 fragments in pBR322 vector
(Fig. 1A). Quikchange PCR was performed on pWN3/4 using the
primer BspEImut. This removed a BspEI restriction site and introduced
a marker mutation resulting in a silent change in NS2A gene. ThisN NS2A gene in NY99 backbone. (A) Schematic representation of the chimeric viruses
d NS2A genes were inserted were inserted into the backbone of NY99 4132 infectious
n a NY99-NS2A/A30P virus containing A30Pmutation in the NY99 NS2Awas generated.
h the NY99-NS2A mutant viruses. (C) Growth kinetics and cytopathicity of NY99-NS2A
assay on Vero cells. A549 cells in 96 well plate were ﬁxed 5d.p.i with 4% formaldehyde
tal violet released was determined at OD620nm (shown as percentage CPE where control
r bars represent standard deviation of duplicate samples (D) Survival of adult (4-week-
ice were i.p. injectedwith 10-, 100- or 1000 pfu of virus. Themice weremonitored for 14
72 M. Audsley et al. / Virology 414 (2011) 63–73plasmidwas renamed as pWN2 (Fig. 1A). All the plasmidswere grown
in DH5α Escherichia coli, and all but pWN1 plasmid were grown at
37 °C. pWN1 plasmid was not stable at 37 °C and was grown at 22°C
for 2–3 days.
Cloning strategy for KUN-NY99 chimaeras
KUN-NY99 5′UTR
To create KUN-NY99 5′UTR, a smaller cloning vector of KUN FLSDX
(Khromykh et al., 1999) was created by digestion with XmaI (NEB)
and extracting the band corresponding to 5136 bp. This fragment was
self-ligated with T4 ligase (NEB) overnight at 4 °C. Quikchange PCR
was performed on this cloning vector to mutate 3 nucleotides
different between KUN and NY99 using the primers KUN-NY99 5′
UTR-F and KUN-NY99 5′UTR-R (Table 1). The resultant KUN-NY99 5′
UTR cloning vector was linearized with XmaI and ligated with the
9978 bp fragment of XmaI-digested FLSDX, creating a full-length
KUN-NY99 5′UTR plasmid (Fig. 2A).
KUN-NY99 5′UTR/3′UTR
The 3′UTR region of pWN1 was ampliﬁed using KUN-NY99 3′UTR-
F and KUN-NY99 3′UTR-R primers, digested with XmaI and XhoI and
cloned into the smaller (XmaI-deleted) KUN-NY99 5′UTR plasmid
digested with XmaI and XhoI. This also introduced amutation into the
FLSDX sequence of NS5 amino acid 877. Quikchange PCR was then
performed using the primers NY99 NS5 877-F and NY99 NS5 877-R to
convert this mutation back to the wildtype FLSDX sequence at NS5
amino acid 877. This smaller cloning plasmid of KUN-NY99 5′UTR/3′
UTR was linearized with XmaI and ligated with the 9978 bp fragment
of XmaI digested FLSDX, creating a full-length KUN-NY99 5′UTR/3′
UTR plasmid (Fig. 2A).
KUN-NY99 3′UTR
KUN-NY99 5′UTR/3′UTR was digested with AgeI and XhoI. The bp
fragment was ligated into AgeI-XhoI digested FLSDX to create KUN-
NY99 3′UTR.
KUN-NY99 NS5-3′UTR
AgeI–NdeI fragment from pWN1 containingmost of the NY99 NS5,
complete 3′UTR and part of pBR322 vector was cloned into AgeI and
NdeI digested FLSDX to produce KUN-NY99 NS5-3′UTR plasmid
(Fig. 3A).
KUN-NY99 5′UTR/NS2A-3′UTR
A full-length cloning vector of NY99 was constructed by cloning
BspEI–BsiWI fragment from pWN2 plasmid into pWN1 vector. This
full length clone pFL-NY99 was found to have a single nucleotide
deletion in NS1 leading to a frameshift and was therefore not used for
producing infectious virus. However, pFL-NY99 plasmid was used to
generate KUN-NY99 5′UTR/NS2A-3′UTR chimeric clone. SphI–NdeI
fragment from pFL-NY99 containing NS2A-3′UTR region of NY99
genome and a part of pBR322 vector was cloned into FLSDX digested
with SphI and NdeI to produce intermediate chimeric plasmid with
deletion of SpHI–SpHI fragment containing most of the NS1 gene.
SphI–SphI fragment from FLSDX containing NS1 genewas then cloned
into the resultant intermediate plasmid to obtain ﬁnal KUN-NY99 5′
UTR/NS2A-3′UTR plasmid (Fig. 3A).
All chimeric plasmids were conﬁrmed by DNA sequencing,
propagated overnight at 37°C and extracted from DH5α E. coli.
Construction of NY99-KUN NS2A chimeras
NY99-NS2A/A30P
To introduce the NS2A A30Pmutation into pWN2, Quikchange PCR
was performed using the primers WNA30P-F and WNA30P-R. Themutated pWN2 was then used to generate NY99-NS2A/A30P mutant
virus (Fig. 4A) in conjunction with pWN1.
NY99-KUN/NS2A and NY99-KUN/NS2A/A30P
These plasmids (Fig. 4A) were generated by cloning BsmI–PshAI
fragments containing KUN wt and A30P-mutated NS2A genes from
FLSDX and FLSDX-NS2A/A30P, respectively, into pWN2 vector
digested with BsmI and PshAI.
All plasmids were conﬁrmed by DNA sequencing and propagated
at 22°C for 3 days.
Generation of NY99 and NY99-KUN NS2A chimeric viruses from
2-plasmid system
pWN1 was digested with BspEI for 2 h at 37 °C followed by BsiWI
for 2 h at 55 °C. The band corresponding to 10926 bp was extracted
from the gel using Wizard SV gel cleanup kit (Promega). pWN2,
pWN2-NS2A/A30P, pWN2-KUN/NS2A and pWN2-KUN/NS2A/A30P
were digested with BspEI and BglI (for easier separation of fragments
in the gel) for 2 h at 37 °C followed by BsiWI for 2 h at 55 °C. The band
corresponding to 2900 bp was extracted as above. The isolated
fragments were ligated overnight at 16 °C using T4 DNA Ligase
(NEB). The ligated DNAs were then linearized with SalI located 20
nucleotides downstream of the 3′-termini of NY99 genome (Fig. 1A)
and puriﬁed by phenol:chloroform extraction. The linearized DNA
was then used for in vitro transcription with T7 RNA polymerase.
Approximately 10 μg of RNA was electroporated into 2×106 BHK21
cells suspended in 400 μl of cold PBS using a 0.2-cm electrode gap
cuvette (Bio-Rad) and a Bio-Rad gene pulser II apparatus. The cells
were incubated at 37 °C for 48–96 h until cytopathic effect (CPE) was
evident. Culture supernatants were harvested and the virus titres
were determined by plaque assay on BHK21 cells.
In vitro transcription and electroporation of KUN-NY99 chimeric viruses
FLSDX, KUN-NY99 5′UTR, KUN-NY99 3′UTR, and KUN-NY99 5′
UTR/3′UTR were digested overnight with XhoI at 37 °C. KUN-NY99
NS5-3′UTR and KUN-NY99 5′UTR/NS2A-3′UTR were digested over-
night with SalI at 37 °C. The DNA was puriﬁed by phenol:chloroform
extraction and approximately 1 μg of DNA was used for in vitro
transcriptionwith Sp6 RNA polymerase (Roche). Approximately 10 μg
of RNA was electroporated into BHK21 cells as above.
Plaque assay
BHK, Vero and A549 cells were seeded into 6-well plates and
infected with wt or mutant viruses for 2 h at 37 °C. The cells were
overlaid with 0.75% LMT agarose in DMEM containing 2% FBS. At the
indicated times post-infection, the cells were ﬁxed with 4% formal-
dehyde and stained with 0.2% crystal violet.
Viral growth kinetics
Vero, A549 and/or C6/36 cells were seeded into 6-well plates and
infected with wt or chimeric virus at an MOI of ~1 in DMEM (Vero),
DMEM:F12 (A549) or RPMI (C6/36) supplemented with 2% FBS . The
cells were incubated at 37 °C (Vero/A549) or 28 °C (C6/36) and
culture supernatants were harvested at the indicated times post-
infection. Viral titres were determined using standard plaque assay on
Vero cells.
Virulence in mice
Groups of 5–10 weanling (18–19 days old) or adult (4 weeks old)
Swiss outbred mice were infected intraperitoneally (i.p.) with 100 μl
of 10-fold serial dilutions of wt or chimeric viruses and monitored for
14 days post-infection for the signs of paralysis or encephalitis. The
lethal dose (50%—LD50) was calculated for each virus by themethod of
Reed and Muench (Reed and Muench, 1938). The experiments were
conducted with approval from the University of Queensland Exper-
imentation Ethics Committee in accordance with the guidelines for
73M. Audsley et al. / Virology 414 (2011) 63–73animal experimentation as set by the National Health and Medical
Research Council, Australia.
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